DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20161424

Cytohistopathological correlation of Papanicolaou smears: a hospital based study

Purwa Rangrao Patil, Shubhangi Narayan Jibhkate

Abstract


Background: Carcinoma of cervix is the second most common cancer in women worldwide and the leading cause of death from cancer in several developing countries including India. The use of the cervical smear (Papanicolaou/Pap) as a screening tool has significantly reduced the incidence of cervical cancer. Cytohistopathological correlation of Pap smear is a widely accepted method of internal quality assurance and helps in the analysis of various factors leading to discrepant diagnosis. With the above view, the present study has been carried out to evaluate the cytohistopathological correlation of the various cervical lesions.

Methods: The study was prospective cross-sectional hospital based study carried out over a period of eight months in which out of 500 pap smears screened, cytohistopathological correlation of 70 cases were obtained.

Results: Specificity in the present study was 84.2% and the sensitivity was 77.7%. The accuracy of Pap smears was 82.1%. The overall correlation between cytology and histopathology was found to be 57% with the highest correlation in the high grade squamous intraepithelial lesion (HSIL) category (87.5%).

Conclusions: The study provides good cytohistopathological correlation especially for high grade lesions. So we believe that the success of screening for cervical cancer is based on collection of adequate materials and correct interpretation of abnormal cells.


Keywords


Carcinoma cervix, Pap smears, Cytohistopathological, Correlation, HSIL, LSIL

Full Text:

PDF

References


GLOBOCAN 2008 (IARC), Section of Cancer Information (8/10/2012). (WHO, 2009b; GLOBOCAN 2002 database, IARC.

Comprehensive cervical cancer controls a guide to essential practice. 2nd edition. World Health Organization 2014. Available at http:appswho.int/iris/bitstream/10665/144785/1/97892411548953_ eng.pdf. Accessed 15 August 2015.

Nandakumar A, Ramnath T, Chaturvedi M. Indian J Med Res. 2009;130(9):219-21.

NIH Consensus Development Conference Statement, 1996. WHO/EUROGIN Joints Experts Meeting Cervical cancer screening, 1996.

Wiener, HG, Klinkhamer P, Schenck U, Arbyn M, Bulten J, Bergeron C, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories. Cytopathology. 2007;18(2):67-78.

Imtiaz F, Hasa WHG, Klinkhamer P, Schenck U, Arbyn M, Bulten J, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories. Cytopathology.2007;18(2):67-78.

Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society Guidelines for the early detection of Cervical neoplasia and cancer. CA Cancer. 2002; 52:342-62.

Sawaya GF, Brown AD, Washington AE, Garber AM. Clinical practice: current approaches to cervical cancer screening. N Engl J Med. 2001; 344:1603-7.

Chhabra Y, Behera BG, Khalkho J, Pati N. Cytomorphological study of PAP smears in pre-cancerous and cancerous lesions. J Cytol 2003; 20(2):64-7.

Ozkara SK, Yıldız K. Retrospective five year analysis of our servicovaginal cytology screening programme under the perspective of Bethesda-2001. Turkish Bulletin of Pathology. 2002;19:119-24.

Yeah GP, Chan KW. The Accuracy of Papanicoaou smear predictions: cytohistological correlation of 283 cases. Hong Kong Med J. 1997;3:373-6.

Gupta S, Sodhani P. Why is high grade squamous intraepithelial neoplasia under-diagnosed on cytology in a quarter of cases? Analysis of smear characteristics in discrepant cases. Indian J Cancer. 2004;41(3):104-8.

Husain OAN. Butler E, Evans DMD. Mac JE, Yule R. Quality control of cervical cytology. J Clin Pathol. 1974;27:935-44.

Kontzoglou K, Moulakakis KG, Konofaos P, Kyriazi M, Kyroudes A, Karakitsos P. The role of liquid-based cytology in the investigation of breast lesions using fine-needle aspiration: a cytohistopathological evaluation. J Surg Oncol. 2005;89(2):75-8.

Frenczy A. The Bethesdab System (TBS): advantages and pitfalls. In: Franco E. New developments in cervical cancer screening and prevention. 1st edition. Europe: Wiley-Blackwell;1997:151-158.

NY Alwahaibi, Sulimi SK, Bai UR. Cytohistological correlation and discrepancy of conventional Papanicolaou smear test with corresponding histopathology: a retrospective study over a 5-years period. East Medit Health J. 2015;21:579.

Abali R, Bacanakgıl BH, Celık S, Aras O, Koca P, Boran B, et al. Histopathological correlation of squamous cell abnormalities detected on cervical cytology. Turk Patoloji Derg. 2011;27(2):144-8.

R Naik, M Minj, R Panda, S Satpathi, PK Behra, K Panda. Cytohistopathological correlation and accuracy of the Pap Smear test in diagnosis of cervical lesions: a hospital based cross sectional study from Odisha, India. Medical Science. 2015;3(3):242-9.

Mihaela M, Simionescu C, Ghica P, Desdemona S. Evaluation of Pap-test Performance by a Cyto-histopathological and Immunocytochemistry Study with Therapeutic implications. Annals of RSCB. 2011;16(2):42-9.

Jain V, Vyas AS, Neoplasia Cyto-Histological correlation (Bethesda system) a study of 276 cases. J cyto Histo. 2010;1:106.

Saha R, Thapa M. Correlation of cervical cytology with cervical histology, Kathmandu Univ Med J. 2005;3:222-4.

Nawaz FHAQ, Aziz AB, Parvez S, Rizvi J. Prevalence of abnormal papani calaou smears and cytohistological correlation. a study from Aga khan university hospital, Pakistan. Asia Pacific J Clinic Onco. 2005;1(4):128-32.

Rasbridge S. One year Audit. Acta cytological. 2005;39:648-1.

Bruce A, Jones, David A, Novis. MD Cervical Biopsy-cytology correlation. a college of American pathologist probe study of 22439 correlations in 348 laboratories. Arch Pathol Lab Med. 1996;120:523-1.

Di BL, Falconieri G, Tomasic G, Colautti I, Bonifacio D, Dudine S. Cervical cytopathology-an evaluation of its accuracy based on cytohistologic comparison. Cancer. 1993;72:3002-6.